Topic: programmed cell death

Anthony Letai discusses how understanding programmed cell death can guide the selection of cancer treatments. The seminar explains how apoptotic signalling can be measured and how these measurements can identify drugs capable of killing cancer cells. Hybrid: New Research Building Auditorium, Georgetown University Medical Center, Washington, DC, and Zoom. Monday 5 October 2026, 16:30–17:30 EDT (America/New_York; UTC−4). Use the attendance registration form or the event’s Zoom link on the organizer page. Organized by Georgetown’s Distinguished Scientist Seminar Series. Letai is Director of the

H. Robert Horvitz's laboratory at MIT is recruiting a research technician to investigate molecular mechanisms of cell-fate determination and programmed cell death in Caenorhabditis elegans. The work includes genetic screens, CRISPR and transgenesis, molecular cloning, fluorescence microscopy, data analysis, animal husbandry, and general laboratory support in a highly integrative research environment.